EUVIMEDEUVIMED entdecken
Crossref

circSERINC3 facilitates STAT3-CDK5 crosstalk to orchestrate immunosuppressive microenvironments in pancreatic Cancer

Min Huang, Xintao Liu, Biao Tang, Xin Tang, Xianlan Ai

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2025.116129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Min Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, The central Hospital of Yongzhou, China; Department of Hepatopancreatobiliary Surgery, YongZhou Hospita…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Pancreatic Neoplasms, Cyclin-Dependent Kinase 5, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circular RNAs (circRNAs) have emerged as critical regulators of tumor immunity, yet their role in orchestrating immunosuppressive microenvironments in pancreatic ductal adenocarcinoma (PDAC) remains unclear. Here, we identify circSERINC3 as a novel immunosuppressive circRNA upregulated in PDAC tissues. Clinical analysis reveals that high circSERINC3 expression correlates with advanced TNM stage, distant metastasis, and poor prognosis in PDAC patients. Functional studies demonstrate that circSERINC3 suppresses CD8+ T-cell cytotoxicity and cytokine secretion (TNF-α, IFN-γ) through stabilizing a cytoplasmic complex with cyclin-dependent kinase 5 (CDK5) and signal transducer and activator of transcription 3(STAT3). Mechanistically, circSERINC3 acts as a molecular scaffold to facilitate STAT3 Ser727 phosphorylation via CDK5 kinase activity, leading to programmed cell death 1 ligand 1(PD-L1) upregulation and JAK/STAT3 pathway activation. Genetic manipulation of circSERINC3 in orthotopic PDAC mouse models confirms its role in promoting tumor growth and reducing survival. Notably, pharmacological inhibition of CDK5 reverses circSERINC3-mediated immunosuppression and restores T-cell effector functions. These findings establish circSERINC3 as a key driver of immunosuppression in PDAC through the CDK5-STAT3-PD-L1 axis, highlighting its potential as a therapeutic target for immunotherapy-resistant PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorPancreatic NeoplasmsCyclin-Dependent Kinase 5Carcinoma, Pancreatic DuctalRNA, CircularHumansAnimalsTumor MicroenvironmentMiceCell Line, TumorMaleFemaleB7-H1 AntigenCD8-Positive T-LymphocytesSignal TransductionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CDK5Immunosuppressive microenvironmentPD-L1PDACSTAT3circSERINC3

Substanzen

STAT3 Transcription FactorCyclin-Dependent Kinase 5STAT3 protein, humanRNA, CircularCDK5 protein, humanB7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Hepatopancreatobiliary Surgery, The central Hospital of Yongzhou, China; Department of Hepatopancreatobiliary Surgery, YongZhou Hospital Affiliated to University of SouthChina, China.
  • Department of Gastrointestinal Surgery, The central Hospital of Yongzhou, China; Department of Gastrointestinal Surgery, YongZhou Hospital Affiliated to University of SouthChina, China. Electronic address: aixianlan123@…

Zitieren

APA

Huang, M., Liu, X., Tang, B., Tang, X., & Ai, X. (2026). circSERINC3 facilitates STAT3-CDK5 crosstalk to orchestrate immunosuppressive microenvironments in pancreatic Cancer. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.116129

Vancouver

Huang M, Liu X, Tang B, Tang X, Ai X. circSERINC3 facilitates STAT3-CDK5 crosstalk to orchestrate immunosuppressive microenvironments in pancreatic Cancer. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2025.116129

BibTeX
@article{Huang2026,
  author = {Huang, Min and Liu, Xintao and Tang, Biao and Tang, Xin and Ai, Xianlan},
  title = {circSERINC3 facilitates STAT3-CDK5 crosstalk to orchestrate immunosuppressive microenvironments in pancreatic Cancer},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2025.116129}
}
Kostenlos starten →